# MTMR7

## Overview
MTMR7 is a gene that encodes the myotubularin-related protein 7, a member of the myotubularin family of proteins, which are characterized by their phosphatase activity. This protein is primarily involved in the regulation of phosphoinositide signaling pathways, playing a crucial role in cellular processes such as membrane trafficking, cell growth, and apoptosis. Myotubularin-related protein 7 is a phosphatase enzyme that specifically dephosphorylates phosphatidylinositol 3-phosphate and inositol 1,3-bisphosphate, and it is predominantly expressed in the brain and neuronal cells (Mochizuki2003Characterization). The protein's activity is enhanced through its interaction with myotubularin-related protein 9, forming a complex that regulates its enzymatic function (Mochizuki2003Characterization). MTMR7 is also implicated in the regulation of vascular smooth muscle cells and has been associated with various diseases, including variant Creutzfeldt-Jakob disease and vascular disorders, highlighting its significance in both neurological and vascular health (Sun2024MTMR7; SanchezJuan2012Genomewide).

## Structure
MTMR7 is a member of the myotubularin family of proteins, characterized by several distinct domains that contribute to its function. The protein contains a protein tyrosine phosphatase (PTP) motif, a SET-interaction domain (SID), and a coiled-coil domain, which are common features in myotubularin proteins (Mochizuki2003Characterization). The coiled-coil domain is crucial for protein interactions, including the formation of complexes with other proteins such as MTMR9, enhancing its enzymatic activity (Mochizuki2003Characterization).

MTMR7 exists in full-length and truncated isoforms. The full-length isoform has a molecular weight of approximately 75.6 kDa, while the truncated isoform lacks the C-terminal coiled-coil domain, potentially affecting its oligomerization and interaction capabilities (Weidner2020Myotubularin-related). The truncated isoform, identified in human colorectal cancer cells, may facilitate nuclear shuttling and interaction with peroxisome proliferator-activated receptor-gamma (PPARγ) (Weidner2020Myotubularin-related).

MTMR7's subcellular localization includes both cytosolic and membrane fractions, with a presence in Golgi-like granules and the cytosol (Mochizuki2003Characterization). The protein's localization and function are influenced by its interaction with PPARγ, where it acts as a nuclear receptor coactivator (Weidner2020Myotubularin-related).

## Function
Myotubularin-related protein 7 (MTMR7) is a phosphatase enzyme involved in the regulation of phosphoinositide signaling pathways, specifically dephosphorylating phosphatidylinositol 3-phosphate (PtdIns(3)P) and inositol 1,3-bisphosphate [Ins(1,3)P2] (Mochizuki2003Characterization). MTMR7 is primarily expressed in the brain and neuronal cells, where it plays a role in cellular signaling and membrane dynamics (Mochizuki2003Characterization). It is localized in both the cytosol and membrane fractions of cells, suggesting its involvement in processes related to membrane trafficking (Mochizuki2003Characterization).

MTMR7 forms a complex with myotubularin-related protein 9 (MTMR9), which enhances its phosphatase activity, indicating a regulatory mechanism for its enzymatic function (Mochizuki2003Characterization). The protein's activity is crucial for maintaining cellular homeostasis, as it regulates the levels of PtdIns(3)P, a lipid involved in various cellular processes such as cell growth and apoptosis (Mochizuki2003Characterization).

In addition to its role in neuronal cells, MTMR7 is also involved in the regulation of vascular smooth muscle cells (VSMCs), where it suppresses glycolysis and phenotypic switching, processes that are critical in vascular diseases (Sun2024MTMR7). This function is mediated through the p62/mTORC1 pathway, highlighting its role in cellular metabolism and proliferation (Sun2024MTMR7).

## Clinical Significance
Mutations and alterations in the MTMR7 gene have been implicated in several diseases and conditions. A genome-wide association study identified a single nucleotide polymorphism (SNP) in the MTMR7 gene, rs4921542, which is associated with a 3.25-fold increased risk of variant Creutzfeldt-Jakob disease (vCJD). This SNP is an intronic variant that suggests a potential role of the phosphatidylinositol pathway in vCJD susceptibility (SanchezJuan2012Genomewide). The study highlights that genetic variations in MTMR7 may contribute to the risk of developing vCJD, a transmissible neurodegenerative disease (SanchezJuan2012Genomewide).

In the context of vascular diseases, MTMR7 is involved in the regulation of vascular smooth muscle cells (VSMCs) and vascular intimal hyperplasia. Alterations in MTMR7 expression can lead to abnormal VSMC proliferation and glucose metabolism, which are associated with conditions like vascular restenosis and atherosclerosis. MTMR7's role in these processes is linked to its regulation of the p62/mTORC1-mediated glucose metabolism pathway (Sun2024MTMR7).

Additionally, MTMR7 is essential for spermatogonial stem cell homeostasis through the PI3K/AKT signaling pathway. Deficiency in MTMR7 leads to excessive proliferation of these cells, indicating its critical role in maintaining normal cell proliferation and preventing conditions characterized by abnormal cell growth (Zhao2019Myotubularin).

## Interactions
Myotubularin-related protein 7 (MTMR7) is known to interact with several proteins, playing a significant role in cellular signaling pathways. MTMR7 has been identified as a cytosolic binding partner of peroxisome proliferator-activated receptor-gamma (PPARγ), particularly in cancer cells with constitutive activation of RAS-ERK1/2 signaling. This interaction enhances PPARγ's transcriptional activity by inhibiting ERK1/2-dependent phosphorylation, which is significant for its potential therapeutic benefits in cancer therapy (Weidner2020Myotubularin-related).

MTMR7 also interacts with myotubularin-related protein 9 (MTMR9), forming a complex that increases MTMR7's enzymatic activity. This interaction is mediated through the coiled-coil domain, which is crucial for their binding (Mochizuki2003Characterization). The MTMR7-MTMR9 complex does not alter the cellular localization of MTMR7, as both proteins are found in the cytosol and membrane fractions (Mochizuki2003Characterization).

Additionally, MTMR7 is involved in modulating the PI3K/AKT signaling pathway, where its depletion leads to activation of this pathway, resulting in increased cell proliferation. This interaction highlights MTMR7's role in regulating cellular growth and survival (Zhao2019Myotubularin).


## References


[1. (Zhao2019Myotubularin) Dan Zhao, Cong Shen, Tingting Gao, Hong Li, Yueshuai Guo, Feng Li, Chenchen Liu, Yuanyuan Liu, Xia Chen, Xi Zhang, Yangyang Wu, Yi Yu, Meng Lin, Yan Yuan, Xiaofang Chen, Xiaoyan Huang, Shenmin Yang, Jun Yu, Jun Zhang, and Bo Zheng. Myotubularin related protein 7 is essential for the spermatogonial stem cell homeostasis via pi3k/akt signaling. Cell Cycle, 18(20):2800–2813, September 2019. URL: http://dx.doi.org/10.1080/15384101.2019.1661174, doi:10.1080/15384101.2019.1661174. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/15384101.2019.1661174)

[2. (Mochizuki2003Characterization) Yasuhiro Mochizuki and Philip W. Majerus. Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9. Proceedings of the National Academy of Sciences, 100(17):9768–9773, July 2003. URL: http://dx.doi.org/10.1073/pnas.1333958100, doi:10.1073/pnas.1333958100. This article has 82 citations.](https://doi.org/10.1073/pnas.1333958100)

[3. (Weidner2020Myotubularin-related) Philip Weidner, Michaela Söhn, Torsten Schroeder, Laura Helm, Veronika Hauber, Tobias Gutting, Johannes Betge, Christoph Röcken, Florian N. Rohrbacher, Vijaya R. Pattabiraman, Jeffrey W. Bode, Rony Seger, Daniel Saar, Ariane Nunes-Alves, Rebecca C. Wade, Matthias P. A. Ebert, and Elke Burgermeister. Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma. Oncogenesis, June 2020. URL: http://dx.doi.org/10.1038/s41389-020-0238-8, doi:10.1038/s41389-020-0238-8. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41389-020-0238-8)

[4. (Sun2024MTMR7) Xiongshan Sun, Yao Yang, Weiwei Zhao, Mingliang Wang, Yingmei Chen, Jia Wang, Dachun Yang, and Yongjian Yang. Mtmr7 suppresses the phenotypic switching of vascular smooth muscle cell and vascular intimal hyperplasia after injury via regulating p62/mtorc1-mediated glucose metabolism. Atherosclerosis, 390:117470, March 2024. URL: http://dx.doi.org/10.1016/j.atherosclerosis.2024.117470, doi:10.1016/j.atherosclerosis.2024.117470. This article has 2 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.atherosclerosis.2024.117470)

[5. (SanchezJuan2012Genomewide) Pascual Sanchez-Juan, Matthew T. Bishop, Yurii S. Aulchenko, Jean-Philippe Brandel, Fernando Rivadeneira, Maksim Struchalin, Jean-Charles Lambert, Philippe Amouyel, Onofre Combarros, Jesus Sainz, Angel Carracedo, Andre G. Uitterlinden, Albert Hofman, Inga Zerr, Hans A. Kretzschmar, Jean-Louis Laplanche, Richard S.G. Knight, Robert G. Will, and Cornelia M. van Duijn. Genome-wide study links mtmr7 gene to variant creutzfeldt-jakob risk. Neurobiology of Aging, 33(7):1487.e21-1487.e28, July 2012. URL: http://dx.doi.org/10.1016/j.neurobiolaging.2011.10.011, doi:10.1016/j.neurobiolaging.2011.10.011. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neurobiolaging.2011.10.011)